Erling T.
- Country
- Norway
- Department
- Neurology
Research Overview
- Efficacy of Botulinum Toxin Type A in Sphenopalatine Ganglion Blockade for Treatment-Refractory Chronic Migraine: A Randomized Controlled Trial
- Efficacy of Eptinezumab as Adjunctive Therapy in Preventing Migraine and Treating Medication Overuse Headache in Patients with Dual Diagnosis
- Efficacy of Botulinum Toxin Type A in Sphenopalatine Ganglion Blockade for Refractory Chronic Cluster Headache Treatment
Data & Insights
Has run more than one trial at 3 of 56 partner sites.
Specializations
Headache Disorders
This investigator specializes in treating complex chronic headache conditions, with particular emphasis on medication overuse headache (MOH) and chronic migraine.
- Medication Overuse Headache Management
- Chronic Migraine Prevention
- Innovative Treatment Approaches
The investigator explores preventive therapies including novel biological treatments for migraine management.
Interventional Procedures
Focuses on advanced image-guided surgical interventions for headache disorders, particularly targeting the sphenopalatine ganglion (SPG).
- Botulinum Toxin Administration
- Precision-Guided Procedures
- Surgical Device Implementation
The investigator utilizes specialized surgical devices for precise therapeutic delivery in treatment-resistant cases.
Neurological Conditions
Specializes in treating chronic cluster headache and other complex neurological pain conditions through innovative therapeutic approaches.
- Treatment-Refractory Cases
- Cluster Headache Management
- Advanced Pain Interventions
The investigator develops targeted treatments for patients who have not responded to conventional therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.